The most recent short interest data has been released for the 08/15/2017 settlement date, which shows a 1,067,199 share decrease in total short interest for Stamps.com Inc. (STMP - Get Report), to 2,869,133, a decrease of 27.11% since 07/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for STMP at the 08/15/2017 settlement increased to 930,110, as compared to 377,813 at the 07/31/2017 report. That brought "days to cover" down to 3.08, a 70.39% decrease from the 10.42 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for STMP at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where STMP had been shorted as a hedge. The chart below shows the one year performance of STMP shares, versus its 200 day moving average. Looking at this chart, STMP's low point in its 52 week range is $84.87 per share, with $220.25 as the 52 week high point — that compares with a last trade of $193.10. STMP makes up 4.28% of the PowerShares DWA Consumer Staples Momentum Portfolio ETF (PSL)
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Iridium Communications Shows Long-Term, Upside Potential
Patient investors in Iridium have done well as the stock has rebounded from its 2016 lows.
Mallinckrodt Tumbles After Filing a Lawsuit Against the HHS on Acthar Gel
The drugmaker files suit against the U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services in order to protect Medicaid patient access to its Acthar gel.